Q&A: What Do FDA’s Recent Medical App Approvals Mean For Industry?

Marc Scheineson, a former US FDA associate commissioner who now heads Alston & Bird’s food and drug law practice, offered insight into the agency's latest moves in regulating medical apps and what industry should watch for.

Interview

Medical app regulation has been a rapidly changing field and area of focus for US FDA over the last several years. Most recently, the agency approved the first direct-to-consumer app-based contraceptive, Natural Cycles, from Natural Cycles Nordic AB. (Also see "FDA Approves Birth Control Mobile App, Vaginal Ring " - Medtech Insight, 10 August, 2018.)

Medtech Insight spoke to Marc Scheineson, an attorney and FDA vet who heads Alston & Bird’s food and drug law...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Approvals

More from Policy & Regulation